Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,332,996
-
Share change
-
-486,288
-
Total reported value
-
$5,362,440
-
Put/Call ratio
-
0%
-
Price per share
-
$1.61
-
Number of holders
-
28
-
Value change
-
-$830,230
-
Number of buys
-
12
-
Number of sells
-
8
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q2 2022
As of 30 Jun 2022,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,332,996 shares.
The largest 10 holders included
Ikarian Capital, LLC, MORGAN STANLEY, Phoenix Holdings Ltd., MACQUARIE GROUP LTD, GROUP ONE TRADING, L.P., Caption Management, LLC, Telemetry Investments, L.L.C., LPL Financial LLC, SIMPLEX TRADING, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.